AI
Thursday, November 01, 2018 9:24:32 AM
SLS - 1.22 Pre-market now at 1.44/1.45
Oppenheimer Initiates Coverage On SELLAS Life Sciences with Outperform Rating, Announces $13 Price Target
Oppenheimer Initiates Coverage On SELLAS Life Sciences with Outperform Rating, Announces $13 Price Target
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
